In the four cohorts reporting gene expression data in metastatic prostate cancer, we observed a significant decrease of ZBTB38 expression levels in metastatic prostate cancer compared to normal/benign prostate tissues, as well as localised prostate cancer (Table 1 and Figure 1a–c). The gene discussed is ZBTB38; the disease is metastatic prostate carcinoma.